Tarik Benidir

Tarik Benidir, MD

Clinical Assistant Professor

Department: MD-UROLOGY
Business Phone: (352) 273-7615
Business Email: tarik.benidir@ufl.edu

About Tarik Benidir

My name is Tarik Benidir, MD, and I am a clinical assistant professor at the University of Florida Department of Urology. I received my medical degree from Queens University School of Medicine in Kingston, Ontario, followed by a residency in urology at the University of Toronto and a urologic oncology fellowship at the Cleveland Clinic in Ohio.

As a urologist that specializes in urologic cancer, I provide surgical management to patients with localized or locally advanced prostate cancer. I offer treatment through robotic prostatectomy for the whole gland as well as prostate focal therapy using various modalities. Furthermore, I am trained to utilize robotic cystectomy with intracorporal diversion for bladder cancer management and other robotic procedures for kidney and ureteral cancers.

My research focuses on the optimization of patient selection for prostate focal therapy and the use of genomics, advanced imaging and artificial intelligence to better treat prostate cancer patients.

In addition to my clinical practice, I enjoy educating and mentoring the next generation of urologists.

Teaching Profile

Courses Taught
2024-2025
BMS6632 Endo and Reproduction

Clinical Profile

Subspecialties
  • Surgical Oncology
  • Urology
Areas of Interest
  • Bladder Cancer
  • Focal Therapy for Prostate Cancer
  • Focal Therapy: High-Intensity Focused Ultrasound for Prostate Cancer (HIFU)
  • Kidney cancer
  • Laparoscopic Radical Nephrectomy
  • Laparoscopic and Robotic Nephroureterectomy
  • Laparoscopic and Robotic Partial Nephrectomy
  • Prostate Cancer
  • Prostate biopsy
  • Radical prostatectomy
  • Robotic Nerve-sparing Radical Prostatectomy
  • Robotic-assisted laparoscopic prostatectomy
  • Transperineal Biopsy for Prostate Cancer
  • Upper Tract Urothelial Cancer
  • Urologic Cancer

Publications

2024
MicroSegNet: A deep learning approach for prostate segmentation on micro-ultrasound images.
Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society. 112 [DOI] 10.1016/j.compmedimag.2024.102326. [PMID] 38211358.
2023
AI-generated R.E.N.A.L.+ Score Surpasses Human-generated Score in Predicting Renal Oncologic Outcomes.
Urology. 180:160-167 [DOI] 10.1016/j.urology.2023.07.017. [PMID] 37517681.
2023
Cell-by-cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression.
The journal of pathology. Clinical research. 9(4):285-301 [DOI] 10.1002/cjp2.319. [PMID] 37073437.
2023
Impact of Prostate Urethral Lift Device on Prostate Magnetic Resonance Image Quality.
The Journal of urology. [DOI] 10.1097/JU.0000000000003156. [PMID] 36630568.
2023
Long-Term Renal Function Following Renal Cancer Surgery: Historical Perspectives, Current Status, and Future Considerations.
The Urologic clinics of North America. 50(2):239-259 [DOI] 10.1016/j.ucl.2023.01.004. [PMID] 36948670.
2023
Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy.
Archives of pathology & laboratory medicine. 147(2):202-207 [DOI] 10.5858/arpa.2021-0409-OA. [PMID] 35700531.
2023
Reply by Authors.
Urology practice. 10(4) [DOI] 10.1097/UPJ.0000000000000400.02. [PMID] 37155955.
2023
The combination of prostate MRI PI-RADS scoring system and a genomic classifier is associated with pelvic lymph node metastasis at the time of radical prostatectomy.
The British journal of radiology. 96(1144) [DOI] 10.1259/bjr.20220663. [PMID] 36745009.
2023
The Feasibility and Value of a Focal Therapy Multidisciplinary Tumor Board, Including Radiographic and Pathological Overreads in Refining the Selection for High Intensity Focused Ultrasound in Prostate Cancer Patients.
Urology practice. 10(4):372-377 [DOI] 10.1097/UPJ.0000000000000400. [PMID] 37103528.
2023
Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSA.
Urology. 176:115-120 [DOI] 10.1016/j.urology.2023.03.014. [PMID] 36965817.
2022
Comparing Pathologic and Survival Outcomes Between Primary and Secondary Muscle Invasive Bladder Cancer When Treated by Radical Cystectomy With or Without Neoadjuvant Chemotherapy.
Urology. 168:137-142 [DOI] 10.1016/j.urology.2022.06.012. [PMID] 35772481.
2022
Computer-Generated R.E.N.A.L. Nephrometry Scores Yield Comparable Predictive Results to Those of Human-Expert Scores in Predicting Oncologic and Perioperative Outcomes.
The Journal of urology. 207(5):1105-1115 [DOI] 10.1097/JU.0000000000002390. [PMID] 34968146.
2022
Editorial Comment.
The Journal of urology. 207(2) [DOI] 10.1097/JU.0000000000002240.01. [PMID] 34766827.
2022
Elevated IsoPSA Selects for Clinically Significant Prostate Cancer Without a Preference for Any Particular Adverse Histopathologic or Radiographic Feature.
Urology. 168:150-155 [DOI] 10.1016/j.urology.2022.05.029. [PMID] 35680047.
2022
Optimizing prediction of new-baseline glomerular filtration rate after radical nephrectomy: are algorithms really necessary?
International urology and nephrology. 54(10):2537-2545 [DOI] 10.1007/s11255-022-03298-y. [PMID] 35842890.
2022
Reply by Authors.
The Journal of urology. 207(5) [DOI] 10.1097/JU.0000000000002390.02. [PMID] 35393896.
2022
The role of enhanced recovery after surgery protocols in the development of acute kidney injury following radical cystectomy.
Urologic oncology. 40(10):453.e1-453.e7 [DOI] 10.1016/j.urolonc.2022.07.004. [PMID] 35953395.
2022
Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate.
European urology focus. 8(6):1575-1582 [DOI] 10.1016/j.euf.2022.05.005. [PMID] 35662504.
2021
Evaluation of patient compliance with the use of scrotal cooling devices.
F&S reports. 2(3):289-295 [DOI] 10.1016/j.xfre.2021.06.007. [PMID] 34553153.
2021
Population-based analysis of perioperative chemotherapy use, interventions requiring hospitalization and atheroembolic events among patients with non-metastatic muscle-invasive bladder cancer.
Cancer medicine. 10(8):2636-2644 [DOI] 10.1002/cam4.3805. [PMID] 33710797.
2018
Understanding how prostate cancer patients value the current treatment options for metastatic castration resistant prostate cancer.
Urologic oncology. 36(5):240.e13-240.e20 [DOI] 10.1016/j.urolonc.2018.01.011. [PMID] 29454590.
2014
Laparoscopic partial nephrectomy for renal cell carcinoma in a horseshoe kidney.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 8(11-12):E918-20 [DOI] 10.5489/cuaj.2289. [PMID] 25553168.
2014
Peritoneal metastases from renal cell carcinoma: Images in urology.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 8(5-6):E391-2 [DOI] 10.5489/cuaj.2067. [PMID] 25024792.
2013
Clavien classification in urology: Is there concordance among post-graduate trainees and attending urologists?
Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 7(5-6):179-84 [DOI] 10.5489/cuaj.505. [PMID] 23826044.
2013
The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer.
Molecular and cellular endocrinology. 381(1-2):140-9 [DOI] 10.1016/j.mce.2013.07.017. [PMID] 23906537.

Education

Fellowship, Urologic Oncology
2021-2023 · Cleveland Clinic
Residency, Urology
2016-2021 · University of Toronto
Medical School
2012-2016 · Queens University School of Medicine

Contact Details

Phones:
Business:
(352) 273-7615
Emails:
Addresses:
Business Street:
1600 SW ARCHER RD
GAINESVILLE FL 32610
US NEWS AND WORLD REPORT BADGES

Florida’s Leading Academic Urology Program

Rated as High Performing Urology Program

Rated as High Performing in Prostate Cancer Surgery